Results 221 to 230 of about 856,388 (330)

Soft-pair corrections to low-angle Bhabha scattering: YFS Monte Carlo approach [PDF]

, 1997
S. Jadach, M. Skrzypek, B. F. L. Ward
openalex   +1 more source

Systemic T Cell Receptor Profiling Reveals Adaptive Immune Activation and Potential Immune Signatures of Diagnosis and Brain Atrophy in Epilepsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin, Sang Bin Hong, Yong Woo Shin, Inpyeong Hwang, Jaeseong Oh, Jihyeon Choi, Narae Kim, Jangsup Moon, Keun‐Hwa Jung, Kyung‐Il Park, Ki‐Young Jung, Kon Chu, Sang Kun Lee   +12 more
wiley   +1 more source

Tests for segregation distortion in higher ploidy F1 populations. [PDF]

G3 (Bethesda)
Gerard D, Ambrosano GB, Pereira GDS, Garcia AAF.   +3 more
europepmc   +1 more source

Calibration and data collection protocols for reliable lattice parameter values in electron pair distribution function studies [PDF]

, 2015
A. M. Milinda Abeykoon, Hefei Hu, Lijun Wu, Yimei Zhu, Simon J L Billinge, A. M. Milinda Abeykoon, Hefei Hu, Lijun Wu, Yimei Zhu, Simon J L Billinge   +9 more
openalex   +1 more source

Structural basis of the radical pair state in photolyases and cryptochromes

, 2022
Andrea Cellini, S. Madan Kumar, Weixiao Yuan Wahlgren, Amke Nimmrich, Antonia Furrer, Daniel James, Maximilian Wranik, Sylvain Aumonier, Emma V. Beale, Florian Dworkowski, Jörg Standfuss, Tobias Weinert, Sebastian Westenhoff   +12 more
openalex   +2 more sources

Annual 12‐Week Dosing Gap of Natalizumab: Clinical Efficacy, Blood Biomarkers, and CSF Cell Composition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Natalizumab (NTZ) is a highly effective therapy for multiple sclerosis (MS); however, its use is limited by the risk of a rare potentially severe opportunistic brain infection, progressive multifocal leukoencephalopathy (PML). Alternative dosing strategies are evaluated to reduce PML risk while still maintaining efficacy, which ...
Regina Berkovich, Tilman Schneider‐Hohendorf, Eric Baetscher, Evan L. Riddle, Marie Deffner, Emily Katsnelson, Janine Ferrant‐Orgettas, Julie Czerkowicz, John Anderson, Susan E. Goelz, Nicholas Schwab   +10 more
wiley   +1 more source

Single-cell multiomics data integration and generation with scPairing. [PDF]

Cell Rep Methods
Niu J, Vasquez-Rios C, Ding J.
europepmc   +1 more source

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi   +13 more
wiley   +1 more source

Network Neuroscience of Human Multitasking: Local Connections Matter. [PDF]

Hum Brain Mapp
Mueckstein M, Hilger K, Heinzel S, Granacher U, Rapp MA, Stelzel C.   +5 more
europepmc   +1 more source

Long-range order and symmetry breaking in projected entangled-pair state models [PDF]

, 2015
Manuel Rispler, Kasper Duivenvoorden, Norbert Schuch   +2 more
openalex   +1 more source